Literature DB >> 640299

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

J Mirouze, J L Selam, T C Pham, E Mendoza, A Orsetti.   

Abstract

Remission of diabetes was attempted in 12 recent acute onset ketosis-prone juvenile diabetes after short term (5 +/- 1 days) but excellent blood glucose control by the external artificial beta-cell. The comparison group comrised patients undergoing traditional treatment (n = 28). Nine (75%) persistent (over 3-14 months of duration) although partial (oral drugs required) remissions were obtained in the former group as compared to 3 (11%) in the latter group (p less than 0.05). Cases which showed remissions after insulin infusion had a plasma insulin response to IV glucagon still present before insulin infusion, and a daily urinary C-peptide excretion significantly enhanced after (p less than 0.01). Urinary C-peptide/blood glucose remained improved during the remission period. Thus, early effective treatment by means of the artificial pancreas may break the vicious circle hyperglycaemia-insulin depletion-hyperglycaemia and lead to frequent and sustained remissions of juvenile diabetes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640299     DOI: 10.1007/BF01219420

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Severe diabetes with remission; report of a case and review of the literature.

Authors:  R HARWOOD
Journal:  N Engl J Med       Date:  1957-08-08       Impact factor: 91.245

3.  [Insulin infusion controlled by continous blood sugar recording].

Authors:  J Mirouze; J L Selam; P Phan Tan Chi
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1976-05

4.  Changes in plasma insulin and glucose tolerance in stable diabetes in a young woman.

Authors:  K Kosaka; R Hagura; R Saito; F Tsukamoto; T Kuzuya
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

5.  Glucose-stimulated insulin secretion during "remission" of juvenile diabetes.

Authors:  B Weber
Journal:  Diabetologia       Date:  1972-07       Impact factor: 10.122

6.  Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.

Authors:  R C Turner; S T McCarthy; R R Holman; E Harris
Journal:  Br Med J       Date:  1976-05-22

7.  Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine.

Authors:  D L Horwitz; A H Rubenstein; A I Katz
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

8.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03

9.  Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.

Authors:  M B Block; M E Mako; D F Steiner; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1972-09       Impact factor: 5.958

10.  Plasma insulin during remission in juvenile diabetes mellitus.

Authors:  K Johansen; H Orskov
Journal:  Br Med J       Date:  1969-03-15
View more
  39 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Prolonged exposure of pancreatic islets isolated from "pre-diabetic" non-obese diabetic mice to a high glucose concentration does not impair beta-cell function.

Authors:  D L Eizirik; E Strandell; S Sandler
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 3.  Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.

Authors:  Rebecca J Brown; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2008-01-24       Impact factor: 4.866

4.  Controlled release micropump for insulin administration.

Authors:  M V Sefton; H M Lusher; S R Firth; M U Waher
Journal:  Ann Biomed Eng       Date:  1979       Impact factor: 3.934

5.  The value of good control.

Authors:  J C Pickup; H Keen
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

6.  Modern management of the insulin dependent diabetic.

Authors:  R Tattersall
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

7.  Remission from insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, newly diagnosed diabetics: role of some hormonal and immunologic factors.

Authors:  G M Nardelli; E Guastamacchia; S Di Paolo; V Lattanzi; A Ciampolillo; P Montedoro; R Giorgino
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

8.  Relation between the degree of initial metabolic decompensation and the duration of the remission phase in type I diabetes mellitus.

Authors:  U Vetter; E Heinze; E Kohne; W M Teller; E Kleihauer
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

9.  Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.

Authors:  M Knip; J Ilonen; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

10.  Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Correction of abnormalities by adequate blood glucose control.

Authors:  J L Selam; J Clot; M Andary; J Mirouze
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.